Jialyu Huang

No ORCID on file · 26 papers in corpus · active 2019-2026

Study types

  • article 2
  • other 1
  • preprint 1
  • review 1

Condition tags

  • endometriosis 3
  • disambig:endometritis 1
other 2026
Journal of affective disorders ·doi:10.1016/j.jad.2026.121642

BACKGROUND: Endometriosis and major depressive disorder (MDD) pose significant global health burdens. Despite pathophysiological overlaps, existing epidemiological studies predominantly examine their unidirectional associations, often const…

review 2026
Journal of assisted reproduction and genetics ·doi:10.1007/s10815-026-03882-6

Female reproductive disorders present significant challenges worldwide. Transfer RNA-derived small RNAs (tsRNAs), a structurally diverse class of non-coding RNAs mainly comprising tRNA halves (tiRNAs) and tRNA-derived fragments (tRFs), have…

article 2025
·doi:10.1016/j.fertnstert.2025.07.313
preprint 2025
·doi:10.2139/ssrn.5766402
2025
Drug design, development and therapy ·doi:10.2147/dddt.s523076

PurposeTo investigate possible differences in cumulative live birth rates (CLBRs) among three progestins medroxyprogesterone acetate (MPA), dydrogesterone (DYG), and Progesterone within the progestin-primed ovarian stimulation (PPOS) protoc…

2025
Drug design, development and therapy ·doi:10.2147/dddt.s551326

BackgroundOverweight and obesity are link to impaired endometrial receptivity and decreased pregnancy success in frozen-thawed embryo transfer (FET) cycles. Depot gonadotropin-releasing hormone agonist (GnRH-a) pretreatment before hormone r…

2024
Frontiers in endocrinology ·doi:10.3389/fendo.2024.1346842

BackgroundPoor oocyte quality remains one of the major challenges for polycystic ovary syndrome (PCOS) patients during in vitro fertilization (IVF) treatment. Granulosa cells (GCs) in PCOS display altered functions and could cause an unfavo…

2024
Cell communication and signaling : CCS ·doi:10.1186/s12964-024-01610-0

ObjectiveRecurrent pregnancy loss (RPL) patients have higher absolute numbers of decidual natural killer (dNK) cells with elevated intracellular IFN-γ levels leading to a pro-inflammatory cytokine milieu, which contributes to RPL pathogenes…

article 2024
·doi:10.1016/j.apmt.2024.102409
2023
International Immunopharmacology ·doi:10.1016/j.intimp.2022.109552

ObjectiveTo investigate the effect of inactivated coronavirus disease 2019 (COVID-19) vaccination on frozen-thawed embryo transfer (FET) outcomes.MethodsThis retrospective cohort study enrolled 1,210 patients undergoing FET cycles in a sing…

2023
Frontiers in endocrinology ·doi:10.3389/fendo.2023.1239903

IntroductionThe clinical impact of SARS-CoV-2 infection on human reproduction remains controversial. This prospective cohort study aimed to assess the effect of prior female SARS-CoV-2 infection on subsequent in vitro fertilization (IVF) ou…

2022
The Journal of infection ·doi:10.1016/j.jinf.2022.09.023
2022
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-022-00896-4

ObjectiveThe present study aimed to evaluate pregnancy and neonatal outcomes in women, with a previous history of wedge resection for interstitial pregnancy, in frozen-thawed embryo transfer (FET) cycles of IVF/ICSI.MethodsThe present study…

2022
Frontiers in endocrinology ·doi:10.3389/fendo.2022.803471

ObjectiveTo evaluate the efficacy of the long-acting gonadotropin-releasing hormone agonist (GnRH-a) administration before hormone replacement treatment for frozen-thawed embryo transfer in women with different times of embryo implantation …

2022
Journal of inflammation research ·doi:10.2147/jir.s347729

PurposeTo investigate the impact of inactivated SARS-CoV-2 vaccination on in vitro fertilization (IVF) outcomes.Patients and methodsThis retrospective cohort study included 2185 patients undergoing fresh IVF cycles from June 1st to Septembe…

2021
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-021-00778-1

BackgroundThe mechanism of recurrent implantation failure (RIF) is unclear at present and poor endometrial receptivity may be one of the leading reasons. This study aims to construct a competing endogenous RNA (ceRNA) network and identify p…

2021
Frontiers in endocrinology ·doi:10.3389/fendo.2021.766601

PurposeTo evaluate the association of endometrial thickness (EMT) with obstetric and neonatal outcomes in women with polycystic ovary syndrome (PCOS).MethodsA total of 1755 subfertile PCOS women with singleton livebirths after frozen-thawed…

2021
Frontiers in endocrinology ·doi:10.3389/fendo.2021.677689

ObjectiveTo evaluate the clinical effect of mild stimulation with letrozole on pregnancy outcomes in ovulatory women undergoing frozen embryo transfer (FET) compared to natural cycle.DesignRetrospective observational study.SettingTertiary c…

2020
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-020-00597-w

BackgroundDecreased endometrial thickness (EMT) has been suggested to be associated with reduced birthweight of in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) newborns. Considering the differences in ovarian stimulation …

2020
Annals of translational medicine ·doi:10.21037/atm-20-1459

BackgroundPeak endometrial thickness (EMT), measured on the end of follicular phase or early luteal phase, is the most widely used marker for endometrial receptivity during infertility treatment. However, the clinical significance of follic…

2019
Frontiers in endocrinology ·doi:10.3389/fendo.2019.00325

Background: The ability of anti-Müllerian hormone (AMH) to predict ovarian response has been studied extensively in gonadotropin-releasing hormone agonist and antagonist treatments, but no information is available regarding its value in pro…

2019
Frontiers in medicine ·doi:10.3389/fmed.2019.00316

The freeze-all strategy has been increasingly employed in the context of in vitro fertilization (IVF) cycles globally, but the relative advantages of this approach are not entirely understood. Herein we sought to assess how maternal age aff…

2019
Drug design, development and therapy ·doi:10.2147/dddt.s210228

PurposeDydrogesterone (DYG) has been demonstrated to be an alternative progestin in the progestin-primed ovarian stimulation (PPOS) protocol with comparable oocyte retrieval and pregnancy outcomes. However, its safety regarding neonatal out…

2019
Drug design, development and therapy ·doi:10.2147/dddt.s212235

ObjectiveFrozen-thawed embryo transfer enables surplus embryos derived from IVF or IVF-ICSI treatment to be stored and transferred in subsequent cycles into a more "physiologic environment". This study aimed to investigate the clinical effe…

2019
Drug design, development and therapy ·doi:10.2147/dddt.s230129

PurposeDydrogesterone (DYG) is an alternative progestin in progestin-primed ovarian stimulation (PPOS) protocol with weaker pituitary suppression than medroxyprogesterone acetate (MPA) in normal ovulatory women. However, the endocrinologica…